All Industries

Top Healthcare Companies

6,371 Healthcare companies, sorted by total funding raised.

Presence

Teletherapy and remote special education services platform for PreK-12 schools providing speech, ...

New York City, United States201–500EdTech, Healthcare
Growth Equity·$402.0M·Nov 2021
ButterflyIPO

Medical technology company making AI-powered handheld ultrasound devices accessible for clinician...

Guilford, United States201–500Artificial Intelligence, Healthcare
Series C·$402.0M·Jan 2019
Color

Population-scale health company delivering genetic testing, cancer screening, and virtual clinica...

Burlingame, United States501–1000Life Sciences, Biotech
Series E·$402.0M·Nov 2021
eMed

Digital health platform specializing in GLP-1 weight-loss programs.

Miami, United States201–500Digital Health, Healthcare
Venture Unknown·$400.0M·Apr 2026
Syneron Bio

Biotech company focused on biologics development.

Beijing, United States51–200Biotech, Healthcare
Venture Unknown·$400.0M·Apr 2026
Tempo

Live home fitness training powered by computer vision.

San Francisco, United States51–200Digital Health, Healthcare
Extension Round·$397.5M·Apr 2021
Maven Clinic

Virtual women's health clinic

New York, United States501–1000Healthcare, Women
Series F·$397.0M·Oct 2024
One MedicalAcquired

One Medical is a membership-based primary care practice delivering high-quality, accessible healt...

San Francisco, United States1001–5000Healthcare
Growth Equity·$390.0M·Aug 2018
Weave CommunicationsIPO

Weave makes communicating with customers easier for businesses by integrating features like texti...

Lehi, United States501–1000Healthcare, Telecommunications
Venture Unknown·$390.0M·Nov 2021
PolicyBazaar

India's largest digital insurance marketplace, enabling consumers to compare and purchase insuran...

Gurugram, India10001+Fintech, Healthcare
Series G Plus·$389.8M·Mar 2021
caresyntax

caresyntax® is a technology and services platform that helps hospitals reduce surgical risk, boos...

San Francisco, United States51–200Healthcare
Series C·$387.5M·Aug 2024
Avenzo Therapeutics

Clinical-stage oncology company developing next-generation cancer therapies, founded in 2022 and ...

San Diego, United States11–50Biotech, Healthcare
Series A·$386.0M·Nov 2024
Voi

Operator of behavioral health and insights platform designed to help and intervene in people at r...

Stockholm, United States501–1000Artificial Intelligence, Climate Tech
Series E·$385.0M·Mar 2024
Hippocratic AI

Safety-focused LLM for healthcare “super staffing”

Palo Alto, United States51–200Artificial Intelligence, Healthcare
Series C·$385.0M·Nov 2025
Cleerly

Cleerly is a healthcare company whose mission is to create digital care pathways to prevent heart...

New York, United States201–500Artificial Intelligence, Healthcare
Series C·$383.0M·Dec 2024
23andMeIPO

Developing new ways to help people make sense of their genetic information

San Francisco Bay Area, United States501–1000Biotech, DNA Testing
Series B·$382.5M·Dec 2020
Musely

Beauty and skincare platform with personalized recommendations.

San Jose, United States201–500E-Commerce, Healthcare
Venture Unknown·$380.0M·May 2026
Talkiatry

Largest national, virtual, in-network psychiatry practice

New York, United StatesHealthcare, Medtech
Series D·$377.0M·Feb 2026
ZocDoc

Online doctor appointment booking platform

New York, United States201–500Healthcare, Marketplace
Series E·$376.9M·Feb 2021
SaludaIPO

Neurostimulation company developing closed-loop spinal cord stimulation technology for chronic pa...

AustraliaBiotech, Healthcare
Growth Equity·$375.0M·Jan 2025
Monogram Health

Monogram Health is a value-based, in-home specialty care provider for patients with chronic kidne...

Nashville, United States501–1000Healthcare
Venture Unknown·$375.0M·Jan 2023
K Health

AI-powered telehealth platform that combines clinical data with medical knowledge to provide pers...

New York, United States201–500Artificial Intelligence, Digital Health
Series F·$372.9M·Jul 2024
Avalyn PharmaceuticalsIPO

Biopharmaceutical company developing improved therapies for idiopathic pulmonary fibrosis (IPF), ...

Seattle, United States51–200Biotech, Healthcare
Series D·$372.5M·Jul 2025
Avalyn

Developing inhaled therapies to treat people with severe respiratory disease.

Boston, United States11–50Biotech, Healthcare
Series D·$372.5M·Jul 2025
Formation Bio

Tech-native pharma company acquiring and developing clinical-stage assets via proprietary sourcin...

New York, United States51–200Artificial Intelligence, Biotech
Series D·$372.0M·Jun 2024